Literature DB >> 6219951

Suppression of in vitro lymphocyte DNA synthesis by killed Pseudomonas aeruginosa.

H R Rubin, R U Sorensen, P A Chase, J D Klinger.   

Abstract

Whole antibiotic-killed classic Pseudomonas aeruginosa organisms elicited human lymphocyte [3H]thymidine (TdR) uptake in vitro after 5 days in culture. However, high concentrations of the same preparation did not elicit [3H]TdR incorporation. The investigation of this lymphocyte unresponsiveness revealed that a high dose of P. aeruginosa, when added to lymphocyte cultures together with optimal concentrations of lymphocyte activators (e.g., plant lectins or whole killed Staphylococcus aureus Cowan 1), caused a potent, nonspecifically expressed inhibition of lymphocyte [3H]TdR uptake in response to these mitogens. High doses of P. aeruginosa were not cytotoxic to lymphocytes, and the inhibition caused was reversed when lymphocytes were washed free of bacteria. The inhibition of [3H]TdR uptake by high-dose P. aeruginosa did not require the generation of adherent suppressor cells or prostaglandin-mediated, steroid-sensitive or radiation-sensitive suppressor mechanisms. At optimal lymphocyte stimulatory concentrations of P. aeruginosa, the addition of indomethacin or the depletion of adherent cells caused an increase in lymphocyte [3H]TdR incorporation. This is consistent with an adherent-cell population regulating [3H]TdR uptake in response to P. aeruginosa via a prostaglandin-dependent pathway. This population was not involved in the inhibition of lymphocyte [3H]TdR uptake by high concentrations of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219951      PMCID: PMC347998          DOI: 10.1128/iai.39.2.630-637.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Cell-mediated immunity in Cryptococcosis.

Authors:  J R Graybill; R H Alford
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

2.  Reversibility of high dose unresponsiveness to concanavalin A in thymus lymphocytes.

Authors:  J Andersson; O Sjöberg; G Möller
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

3.  Prolonged survival of skin allografts in leprosy patients.

Authors:  S H Han; R S Weiser; S T Kau
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Jan-Mar

4.  In vitro and in vivo cellular immunity in anergic miliary tuberculosis.

Authors:  J Waxman; M Lockshin
Journal:  Am Rev Respir Dis       Date:  1973-04

5.  Immunosuppression in Gambian trypanosomiasis.

Authors:  B M Greenwood; H C Whittle; D H Molyneux
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

6.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

7.  Humoral and cellular immunity in the anergic tuberculosis patient. A prospective study.

Authors:  S J Zeitz; J H Ostrow; P P Van Arsdel
Journal:  J Allergy Clin Immunol       Date:  1974-01       Impact factor: 10.793

8.  Lymphotoxin production by lymphocytes from leprosy patients.

Authors:  S H Han; R S Weiser; J J Tseng
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Jul-Sep

9.  Cutaneous sensitivity and in vitro responsiveness of lymphocytes in patients with disseminated coccidioidomycosis.

Authors:  G Opelz; M I Scheer
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

10.  In vitro lymphocyte response to Treponema refringens im human syphilis.

Authors:  D M Musher; R F Schell; J M Knox
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

View more
  6 in total

1.  Inhibitory and stimulatory effects of Pseudomonas aeruginosa pyocyanine on human T and B lymphocytes and human monocytes.

Authors:  A J Ulmer; J Pryjma; Z Tarnok; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Suppression of the delayed-type hypersensitivity and cell-mediated immune responses to Listeria monocytogenes induced by Pseudomonas aeruginosa.

Authors:  L L Blackwood; T Lin; J I Rowe
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

3.  Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases.

Authors:  T G Theander; A Kharazmi; B K Pedersen; L D Christensen; N Tvede; L K Poulsen; N Odum; M Svenson; K Bendtzen
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

4.  Suppression of lymphocyte proliferation by Pseudomonas aeruginosa: mediation by Pseudomonas-activated suppressor monocytes.

Authors:  T B Issekutz; J M Stoltz
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

5.  In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.

Authors:  R U Sorensen; J D Klinger; H A Cash; P A Chase; D G Dearborn
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

6.  Decreased delayed-type hypersensitivity and increased protection to Listeria monocytogenes seen in mice infected with mucoid and nonmucoid Pseudomonas aeruginosa.

Authors:  L L Blackwood
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.